Target Recalls Up & Up Baby Wipes After FDA Finds Bacteria

Target recalled eight Up & Up baby wipe products on June 5 after the Food and Drug Administration (FDA) confirmed Burkholderia cepacia complex and Burkholderia gladioli bacteria in product samples. The affected wipes, manufactured by Turkish supplier Sapro Temizlik Urunleri between November 2025 and May 2026, were sold at Target stores nationwide and on Target.com, in packages from 20-count single pouches to 1,200-count bulk boxes, and are predominantly used on newborns, infants, and young children.

Customers noticed problems before any laboratory testing began. Reports of discolored wipes, skin irritation, eye irritation, and infections reached both Target and Sapro. The manufacturer has not commented publicly, and Target says those reports “remain under investigation.”

The Eight Products Pulled from Shelves

The recall covers two product lines. Up & Up Fragrance Free Baby Wipes were pulled in five package sizes: 20, 72, 216, 800, and 1,200 count. Up & Up Fresh Cucumber Scented Baby Wipes were pulled in three: 72, 216, and 800 count. The UPC code printed on every package is the fastest way to confirm whether a product is included.

Per the FDA's official recall notice for the Up & Up baby wipes, the fragrance-free lots carry manufacturing date codes from November 7, 2025 (071125X/XX) through May 5, 2026 (050526X/XXX), with expiration dates running from May 10, 2028 to November 5, 2028. The cucumber-scented lots cover a narrower window: December 29 and 30, 2025 only, with expirations in late June 2028.

Manufacturing date codes appear on packaging as a day-month-year string followed by letter characters. November 7, 2025 reads as “071125X/XX”; May 5, 2026 reads as “050526X/XXX.” Parents who bought large bulk packs and still have wipes in rotation should check both the UPC and the date code before opening another pouch.

Why Newborns Bear the Worst Risk

Burkholderia cepacia complex (Bcc) comprises 24 closely related bacterial species, each an opportunistic pathogen found broadly in soil and water. Research in the American Society for Microbiology's Clinical Microbiology Reviews found that Bcc has been isolated from baby wipes, bathing washcloths, nasal sprays, lotions, and mouthwash, alongside prescription pharmaceuticals. Its three-chromosome genome gives the complex unusual mutation capacity, and its metabolic versatility lets it adapt to conditions hostile to most competing bacteria.

In healthy adults with intact skin, contact with Bcc-contaminated wipes generally causes no infection. A minor cut raises that to a localized skin infection. The gap for newborns and young children is biological: immature immune systems can't contain the bacteria at the skin barrier, and a contact-level exposure can progress to bacteria in the bloodstream, producing sepsis or pneumonia. Both outcomes appear in the FDA's recall notice as potentially life-threatening.

The U.S. Centers for Disease Control and Prevention (CDC) notes that Bcc bacteria are often resistant to common antibiotics, making infections significantly harder to treat once established. That antibiotic resistance profile is part of why clinicians treat Bcc exposure in vulnerable patients with particular caution.

The products are predominantly used on newborns, infants, and young children, who are particularly vulnerable to opportunistic infection due to their immature immune systems.

Target's recall statement included the passage above to identify why the risk is concentrated in this specific user population. Burkholderia gladioli, co-detected in the samples, is a related opportunistic pathogen; the FDA lists both organisms together in its contamination warning.

Historically, Bcc drew its most intense clinical scrutiny in cystic fibrosis (CF) patient communities, where the bacteria can trigger “cepacia syndrome,” a rapid deterioration of lung function documented as frequently fatal. That research history drove decades of attention to how Bcc survives in water-based environments, and the findings apply directly to consumer product manufacturing: the bacteria form biofilms, dense protective colonies that allow them to persist where standard preservation chemistry fails.

Discoloration Was the First Warning

A sealed wipe pouch should look the same a year after production as it did on day one. Color change inside that kind of sterile packaging is biologically significant. The customers who first spotted discolored wipes were identifying the earliest visible indicator of microbial activity without knowing it, and those discoloration complaints arrived alongside accounts of skin irritation, eye irritation, and apparent infections in babies who had used the product.

Reports reached Sapro Temizlik Urunleri as well, before any laboratory testing was conducted. Additional complaints filed on SaferProducts.gov, the federal database for product safety reports, cited rashes and fungal infections tied to the wipes. Their combined volume prompted the FDA to test product samples, which confirmed both Bcc and Burkholderia gladioli. Target issued the voluntary recall on June 5.

Baby wipes are regulated as cosmetics under U.S. law. Target's recall is the company's own voluntary action; the FDA's role was to conduct the laboratory testing that confirmed contamination and publish the safety notice. Target says it is “coordinating with the manufacturer” but has provided no timeline for the investigation's conclusion. What remains unknown is where in the supply chain contamination entered: whether the source was manufacturing water, raw materials, or the production environment itself. Sapro Temizlik Urunleri, which has produced wet wipes for global retail brands since 1997, has not responded to press inquiries.

The Bacteria's Track Record in Consumer Products

Prior Recalls and the Industry Pattern

This is not the first Burkholderia recall in the baby wipe category. In October 2014, Newtek Disposables pulled wipes sold under more than half a dozen brand names after consumer complaints of odor and discoloration triggered testing that confirmed B. cepacia contamination at the company's McElhattan, Pennsylvania facility. Brands affected included Member's Mark at Sam's Club, Cuties and Well Beginnings at Walgreens, Simply Right, Kidgets, and Tender Touch. As of late October 2014, the source had not been identified, and the facility had halted shipments while the investigation continued. The initiating complaint in both cases: a product that visibly looked wrong.

Research in Clinical Microbiology Reviews by the American Society for Microbiology puts the category-wide frequency in numbers. Bcc bacteria were involved in more than a third of nonsterile product recalls over a seven-year period studied, and were the single most common bacterial contaminant in nonsterile product samples analyzed during a 2012 window. Baby wipes and bathing washcloths appeared on that contaminated list alongside hand sanitizers, gas relief drops, and preoperative skin solutions.

• 34% of nonsterile product recalls from 2004 to 2011 involved Bcc bacteria, per ASM's Clinical Microbiology Reviews
• 39% of bacterial species found in contaminated nonsterile products during a 2012 sampling period were Bcc strains
• 24 closely related species make up the complex, with different virulence profiles across immunocompromised populations

How Bcc Survives in Sealed Products

The mechanism behind the bacteria's persistence in moist consumer products is documented in research on Burkholderia cepacia complex contamination in healthcare environments: biofilm formation. Bcc bacteria produce a self-secreted matrix that encases their colonies, shielding them from biocides and preservatives. The protection functions at very low nutrient levels, so the bacteria don't need a rich food source to maintain their colonies inside a sealed product.

A sealed wipe pouch provides moisture, a fibrous substrate, and limited exposure to oxygen or competing organisms. Standard preservation chemistry, developed primarily for gram-positive bacteria and fungal contamination, often underperforms against Bcc's biofilm-encased colonies. That gap between standard preservation and the bacteria's actual tolerance is the recurring condition in Bcc-related product recalls going back more than a decade.

Returning the Wipes for a Refund

Target is accepting returns at any store location, with a full refund on all affected products. No receipt requirement appears in the recall notice. Bringing the original packaging allows store staff to scan the UPC and confirm eligibility, making the process faster, but the refund covers all recalled lots regardless. Parents who made purchases online can contact Guest Relations directly for return assistance.

Target Guest Relations is available at 1-800-440-0680 from 7 a.m. to 10 p.m. Central time daily. The line handles both in-store and online purchase inquiries about the recall.

If a child who used these wipes develops skin irritation, worsening eye discomfort, fever, or any sign of infection that appears to spread beyond the initial contact area, contact a pediatrician promptly. The bacteria confirmed in the wipes can enter the bloodstream in infants and young children, and symptoms that escalate warrant medical evaluation rather than a wait-and-see approach.

Target's investigation is ongoing. No cause-of-contamination finding has been published, and no timeline for conclusions has been made publicly available.

Frequently Asked Questions

How Do I Know If My Up & Up Baby Wipes Are Part of the Recall?

Check the UPC code on your package against the eight codes in the table above. If the UPC matches, confirm the manufacturing date code: fragrance-free wipes fall in the recall window if the date code runs from November 7, 2025 (071125X/XX) to May 5, 2026 (050526X/XXX); cucumber-scented wipes are affected if the code reads December 29 or 30, 2025 (291225X/XX or 301225X/XX). When uncertain, stop using the wipes and return them to any Target store for a full refund.

What Symptoms Should I Watch for in My Baby?

Customers reported skin irritation, eye irritation, and infections after using the recalled wipes. In newborns and infants, watch for redness or irritation at skin contact sites, unusual fussiness, fever, or eye discharge. Any symptom that worsens or spreads beyond the initial contact area warrants a call to a pediatrician; the bacteria confirmed in these wipes can cause bloodstream infections in young children.

Do I Need a Receipt to Get a Refund?

Target's recall announcement says consumers should return the recalled products to any Target store for a full refund, with no receipt requirement listed in the official notice. Bringing the original packaging with a scannable UPC will speed the process, but the refund covers all affected product within the recalled UPC codes.

Are All Up & Up Baby Wipes Recalled?

No. The recall covers specific lots of two products only: Up & Up Fragrance Free Baby Wipes and Up & Up Fresh Cucumber Scented Baby Wipes, within the eight UPC codes and manufacturing date windows listed in the FDA's recall notice. Other Up & Up wipe products with different UPC codes or outside those date windows are not part of this recall.

What Should I Do if My Baby Already Used These Wipes?

If your child used the recalled wipes and shows no symptoms, the FDA's notice indicates that healthy infants without broken skin are at lower risk of serious infection. If skin irritation, redness, eye irritation, or fever has developed, contact a pediatrician. The bacteria confirmed in these wipes can cause bloodstream infections in newborns and young children, and any symptom that appears to progress warrants prompt medical evaluation.